Elevated plasma xanthine oxidoreductase activity predicts cardiovascular events in patients with heart failure with preserved ejection fraction

31 August 2019 (09:30 - 09:45)
Organised by:
Congress Presentation Part of: HFpEF: What's new in 2019 Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by